#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    IgA nephropathy Henoch-Schonlein purpura Renal cell carcinoma Marginal zone lymphoma recurrent Gastroenteropancreatic neuroendocrine tumour disease Glioblastoma Choroid melanoma Astrocytoma Skin angiosarcoma Hypergammaglobulinaemia benign monoclonal Vulval cancer Primary amyloidosis Small cell lung cancer recurrent Chronic myeloid leukaemia Graft versus host disease More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Diagnostics Idiopathic pulmonary fibrosis – Life with Disease Rosai-Dorfman syndrome – Basic Information Pituitary-dependent Cushing’s syndrome – Life with Disease Glomerulonephritis membranous Cholangitis sclerosing – Life with Disease Lymphatic malformation – Basic Information Glycogen storage disease type II Phenylketonuria – Treatment Usher’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Riboflavin Sodium Phosphate Bgb-A445 Cenerimod Olodaterol Methylprednisolone Acetate GSKVX000000025896 Sepiapterin Nanatinostat Lazertinib L-ALANINE Nitric Oxide Gad20-209-Fsp-A4 Resiquimod Sulfate Piritramide Ethambutol Pivekimab Sunirine Loncastuximab Tesirine Gsk4532990A Sym023 Nipocalimab More therapies…

    Learn about Your Condition

    Peritoneal cancer index Albuminuria Diabetic foot infection Non-small cell lung cancer Penile squamous cell carcinoma Mechanical ventilation Hand dermatitis Bone hypertrophy Perineal injury Metabolic syndrome Hyperchylomicronaemia Hypersensitivity Round cell liposarcoma Osteoporosis Hyperthyroidism More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Primary immunodeficiency syndrome

  • Long-term safety and effectiveness study of leniolisib for patients with primary immunodeficiency and immune system problems

    Recruiting

    2 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Leniolisib Phosphate
    Spain

  • Study on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Hyaluronidase (Human Recombinant)
    • Human Normal Immunoglobulin
    Czechia Denmark Germany Greece The Netherlands Poland +2

  • Autologous CD4+ T-Cell Gene Therapy for X-linked Hyper-IgM Syndrome Type 1 in Patients with X-linked Hyper-IgM Syndrome Type 1

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • HAEMOPHILUS TYPE B POLYSACCHARIDE CONJUGATED TO TETANUS TOXOID ADSORBED ON ALUMINIUM PHOSPHATE
    • HEPATITIS B SURFACE ANTIGEN (RDNA) ADSORBED ON ALUMINIUM PHOSPHATE [PRODUCED IN S. CEREVISAE CELLS BY RDNA]
    Italy

  • Study on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Hyaluronidase (Human Recombinant)
    • Human Normal Immunoglobulin
    Czechia Denmark Germany Greece The Netherlands Poland +2

  • Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Selective polysaccharide antibody deficiency
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Human Normal Immunoglobulin
    The Netherlands

  • Study on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Primary immunodeficiency syndrome
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Germany Hungary Italy Poland Slovakia

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!